Full text is available at the source.
Abstract
Geroscience suggests that cardiovascular disease (CVD) may stem from a decline in mechanisms that counteract age-related molecular damage.
- Cardiovascular disease is often linked to multimorbidity and frailty in older patients.
- Aging negatively impacts prognosis and treatment responses for CVD.
- Resilience mechanisms in aging may influence the development and progression of CVD.
- Gerotherapeutics aim to enhance these resilience mechanisms to prevent chronic diseases and improve overall healthspan.
- Some gerotherapeutic strategies are already being utilized in CVD management, indicating their potential to transform patient care.
Simplified